Cyclin-dependent kinase-like function is shared by the beta and gamma subset of the conserved herpesvirus protein kinases

PLoS Pathogens

Volumn 6, Issue 9, 2010, Pages

  Kuny, Chad V ^a   Chinchilla, Karen ^b   Culbertson, Michael R ^b   Kalejta, Robert F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; EPITOPE; LAMIN A; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

ALLELE; ANIMAL CELL; ARTICLE; BETAHERPESVIRINAE; CELL NUCLEUS INCLUSION BODY; ENZYME ACTIVITY; GAMMAHERPESVIRINAE; GENETIC CONSERVATION; MEMBRANE DAMAGE; NOMENCLATURE; NONHUMAN; NUCLEAR LAMINA; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; BONE TUMOR; CELL FRACTIONATION; CELL NUCLEUS; CYTOPLASM; ENZYMOLOGY; GENETICS; HERPES VIRUS INFECTION; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHOSPHORYLATION; PHYLOGENY; TUMOR CELL CULTURE; WESTERN BLOTTING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

BETAHERPESVIRINAE; BLOTTING, WESTERN; BONE NEOPLASMS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASES; CYTOPLASM; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HUMANS; NUCLEAR LAMINA; OSTEOSARCOMA; PHOSPHORYLATION; PHYLOGENY; PROTEIN KINASES; RETINOBLASTOMA PROTEIN; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 78149328426     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001092     Document Type: Article

References (121)

1. Alberts B (2002) Molecular biology of the cell. New York: Garland Science. xxxiv, [1548].
2. Arslan MA, Kutuk O, Basaga H (2006) Protein kinases as drug targets in cancer. Curr Cancer Drug Targets 6: 623-634.
3. Trofe J, Pote L, Wade E, Blumberg E, Bloom RD (2008) Maribavir: a novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother 42: 1447-1457.
4. Drew WL (1991) Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance. J Acquir Immune Defic Syndr 4 Suppl 1: S42-46.
5. Roizman B, Knipe DM, Whitley RJ (2007) Herpes Simplex Viruses. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lippincott Williams and Wilkins. pp 2502-2601.
6. Cohen JI, Straus SE, Arvin AM (2007) Varicella-Zoster Virus Replication, Pathogenesis, and Management. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lipincott, Williams, and Wilkins. pp 2774-2818.
7. Mocarski ES, Shenk T, Pass RF (2007) Cytomegaloviruses. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lipincott, Williams, and Wilkins. pp 2702-2772.
8. Yamanashi K, Mori Y, Pellett PE (2007) Human Herpesviruses 6 and 7. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lipincott, Williams, and Wilkins. pp 2819-2845.
9. Ganem D (2007) Kaposi's Sarcoma-associated Herpesvirus. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lipincott, Williams, and Wilkins. pp 2847-2888.
10. Kieff ED, Rickinson AB (2007) Epstein-Barr Virus and Its Replication. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lippincott, Williams, and Wilkins. pp 2603-2654.
11. Wiebe MS, Traktman P (2007) Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell Host Microbe 1: 187-197.
12. Punjabi A, Traktman P (2005) Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J Virol 79: 2171-2190.
13. Gershburg E, Pagano JS (2008) Conserved herpesvirus protein kinases. Biochim Biophys Acta 1784: 203-212.
14. McGeoch DJ, Davison AJ (1986) Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res 14: 1765-1777.
15. Griffin AM, Boursnell ME (1990) Analysis of the nucleotide sequence of DNA from the region of the thymidine kinase gene of infectious laryngotracheitis virus; potential evolutionary relationships between the herpesvirus subfamilies. J Gen Virol 71 (Pt 4): 841-850.
16. Vende P, Taraporewala ZF, Patton JT (2002) RNA-binding activity of the rotavirus phosphoprotein NSP5 includes affinity for double-stranded RNA. J Virol 76: 5291-5299.
17. Chung TD, Wymer JP, Smith CC, Kulka M, Aurelian L (1989) Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J Virol 63: 3389-3398.
18. Britt WJ, Auger D (1986) Human cytomegalovirus virion-associated protein with kinase activity. J Virol 59: 185-188.
19. Benetti L, Munger J, Roizman B (2003) The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol 77: 6567-6573.
20. Ogg PD, McDonell PJ, Ryckman BJ, Knudson CM, Roller RJ (2004) The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 319: 212-224.
21. Morris JB, Hofemeister H, O'Hare P (2007) Herpes simplex virus infection induces phosphorylation and delocalization of emerin, a key inner nuclear membrane protein. J Virol 81: 4429-4437.
22. Leach N, Bjerke SL, Christensen DK, Bouchard JM, Mou F, et al. (2007) Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J Virol 81: 10792-10803.
23. Mou F, Forest T, Baines JD (2007) US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J Virol 81: 6459-6470.
24. Shugar D (1999) Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases. Pharmacol Ther 82: 315-335.
25. Smith RF, Smith TF (1989) Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and EpsteinBarr virus. J Virol 63: 450-455.
26. Chee MS, Lawrence GL, Barrell BG (1989) Alpha-, beta and gammaherpes viruses encode a putative phosphotransferase. J Gen Virol 70 (Pt 5): 1151-1160.
27. Kawaguchi Y, Kato K (2003) Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Rev Med Virol 13: 331-340.
28. Purves FC, Ogle WO, Roizman B (1993) Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc Natl Acad Sci U S A 90: 6701-6705.
29. Heineman TC, Cohen JI (1995) The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J Virol 69: 7367-7370.
30. Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, et al. (1998) The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A 95: 11969-11974.
31. Gershburg E, Raffa S, Torrisi MR, Pagano JS (2007) Epstein-Barr virus encoded protein kinase (BGLF4) is involved in production of infectious virus. J Virol 81: 5407-5412.
32. Prichard MN, Gao N, Jairath S, Mulamba G, Krosky P, et al. (1999) A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol 73: 5663-5670.
33. Tanaka M, Nishiyama Y, Sata T, Kawaguchi Y (2005) The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0. Virology 341: 301-312.
34. Izumiya Y, Izumiya C, Van Geelen A, Wang DH, Lam KS, et al. (2007) Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP. J Virol 81: 1072-1082.
35. Stevenson D, Colman KL, Davison AJ (1994) Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J Gen Virol 75 (Pt 2): 317-326.
36. Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, et al. (2005) Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86: 3215-3225.
37. van Zeijl M, Fairhurst J, Baum EZ, Sun L, Jones TR (1997) The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231: 72-80.
38. Asai R, Kato A, Kato K, Kanamori-Koyama M, Sugimoto K, et al. (2006) Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J Virol 80: 5125-5134.
39. Morrison EE, Wang YF, Meredith DM (1998) Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J Virol 72: 7108-7114.
40. Long MC, Leong V, Schaffer PA, Spencer CA, Rice SA (1999) ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J Virol 73: 5593-5604.
41. Krosky PM, Baek MC, Jahng WJ, Barrera I, Harvey RJ, et al. (2003) The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 77: 7720-7727.
42. Marschall M, Freitag M, Suchy P, Romaker D, Kupfer R, et al. (2003) The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311: 60-71.
43. Wolf DG, Courcelle CT, Prichard MN, Mocarski ES (2001) Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A 98: 1895-1900.
44. Krosky PM, Baek MC, Coen DM (2003) The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 77: 905-914.
45. Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, et al. (2009) Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog 5: e1000275.
46. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, et al. (2008) Phosphorylation of retinoblastoma protein by viral protein with cyclindependent kinase function. Science 320: 797-799.
47. Prichard MN, Sztul E, Daily SL, Perry AL, Frederick SL, et al. (2008) Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J Virol 82: 5054-5067.
48. Cano-Monreal GL, Tavis JE, Morrison LA (2008) Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase. Virology 374: 1-10.
49. Kawaguchi Y, Kato K, Tanaka M, Kanamori M, Nishiyama Y, et al. (2003) Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J Virol 77: 2359-2368.
50. Kenyon TK, Lynch J, Hay J, Ruyechan W, Grose C (2001) Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol 75: 8854-8858.
51. Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, et al. (2009) Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication. J Biol Chem.
52. Kamil JP, Coen DM (2007) Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65. J Virol 81: 10659-10668.
53. Prichard MN, Britt WJ, Daily SL, Hartline CB, Kern ER (2005) Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol 79: 15494-15502.
54. Ansari A, Emery VC (1999) The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol 73: 3284-3291.
55. Hamza MS, Reyes RA, Izumiya Y, Wisdom R, Kung HJ, et al. (2004) ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway. J Biol Chem 279: 38325-38330.
56. Meng Q, Hagemeier SR, Kuny CV, Kalejta RF, Kenney SC. Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J Virol 84: 4524-4533.
57. Ng TI, Ogle WO, Roizman B (1998) UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241: 37-48.
58. Daikoku T, Shibata S, Goshima F, Oshima S, Tsurumi T, et al. (1997) Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology 235: 82-93.
59. Gershburg E, Marschall M, Hong K, Pagano JS (2004) Expression and localization of the Epstein-Barr virus-encoded protein kinase. J Virol 78: 12140-12146.
60. Michel D, Pavic I, Zimmermann A, Haupt E, Wunderlich K, et al. (1996) The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol 70: 6340-6346.
61. De Bolle L, Michel D, Mertens T, Manichanh C, Agut H, et al. (2002) Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. Mol Pharmacol 62: 714-721.
62. Isegawa Y, Miyamoto Y, Yasuda Y, Semi K, Tsujimura K, et al. (2008) Characterization of the human herpesvirus 6 U69 gene product and identification of its nuclear localization signal. J Virol 82: 710-718.
63. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L (2008) Genome- wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog 4: e1000100.
64. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
65. Helt AM, Galloway DA (2003) Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24: 159-169.
66. Hume AJ, Kalejta RF (2009) Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div 4: 1.
67. Kamil JP, Hume AJ, Jurak I, Munger K, Kalejta RF, et al. (2009) Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc Natl Acad Sci U S A 106: 16823-16828.
68. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, et al. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
69. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, et al. (1996) Cyclin encoded by KS herpesvirus. Nature 382: 410.
70. Knudsen ES, Wang JY (1996) Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 271: 8313-8320.
71. Knudsen ES, Wang JY (1997) Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 17: 5771-5783.
72. Lee CP, Huang YH, Lin SF, Chang Y, Chang YH, et al. (2008) Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82: 11913-11926.
73. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, et al. (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22: 832-853.
74. Mettenleiter TC (2002) Herpesvirus assembly and egress. J Virol 76: 1537-1547.
75. Heald R, McKeon F (1990) Mutations of phosphorylation sites in lamin A that prevent nuclear lamina disassembly in mitosis. Cell 61: 579-589.
76. Cano-Monreal GL, Wylie KM, Cao F, Tavis JE, Morrison LA (2009) Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology 392: 137-147.
77. Lee MG, Nurse P (1987) Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327: 31-35.
78. Reed SI, Wittenberg C (1990) Mitotic role for the Cdc28 protein kinase of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 87: 5697-5701.
79. Ninomiya-Tsuji J, Nomoto S, Yasuda H, Reed SI, Matsumoto K (1991) Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation. Proc Natl Acad Sci U S A 88: 9006-9010.
80. Verschuren EW, Jones N, Evan GI (2004) The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85: 1347-1361.
81. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016.
82. Everett RD, Murray J (2005) ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79: 5078-5089.
83. Ishov AM, Stenberg RM, Maul GG (1997) Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol 138: 5-16.
84. Saffert RT, Kalejta RF (2008) Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virology 3: 265-277.
85. Tavalai N, Stamminger T (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783: 2207-2221.
86. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J (1996) The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229: 155-158.
87. Saffert RT, Kalejta RF (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80: 3863-3871.
88. Maul GG, Guldner HH, Spivack JG (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74 (Pt 12): 2679-2690.
89. Livingston CM, Ifrim MF, Cowan AE, Weller SK (2009) Virus-Induced Chaperone-Enriched (VICE) domains function as nuclear protein quality control centers during HSV-1 infection. PLoS Pathog 5: e1000619.
90. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95: 41-53.
91. Baek MC, Krosky PM, Pearson A, Coen DM (2004) Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus- infected cells and in vitro by the viral UL97 protein kinase. Virology 324: 184-193.
92. Kudoh A, Daikoku T, Ishimi Y, Kawaguchi Y, Shirata N, et al. (2006) Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J Virol 80: 10064-10072.
93. Lee CP, Chen JY, Wang JT, Kimura K, Takemoto A, et al. (2007) EpsteinBarr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J Virol 81: 5166-5180.
94. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, et al. (2003) Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77: 851-861.
95. Jault FM, Jault JM, Ruchti F, Fortunato EA, Clark C, et al. (1995) Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69: 6697-6704.
96. Marschall M, Marzi A, aus dem Siepen P, Jochmann R, Kalmer M, et al. (2005) Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem 280: 33357-33367.
97. McLaughlin-Drubin ME, Munger K (2009) The human papillomavirus E7 oncoprotein. Virology 384: 335-344.
98. Mou F, Wills EG, Park R, Baines JD (2008) Effects of lamin A/C, lamin B1, and viral US3 kinase activity on viral infectivity, virion egress, and the targeting of herpes simplex virus U(L)34-encoded protein to the inner nuclear membrane. J Virol 82: 8094-8104.
99. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
100. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, et al. (2009) Cyclindependent kinases: a family portrait. Nat Cell Biol 11: 1275-1276.
101. Ahn JH, Hayward GS (1997) The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71: 4599-4613.
102. Adamson AL, Kenney S (2001) Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75: 2388-2399.
103. Wileman T (2007) Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design? Annu Rev Microbiol 61: 149-167.
104. Burch AD, Weller SK (2004) Nuclear sequestration of cellular chaperone and proteasomal machinery during herpes simplex virus type 1 infection. J Virol 78: 7175-7185.
105. Burch AD, Weller SK (2005) Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol 79: 10740-10749.
106. Nozawa N, Yamauchi Y, Ohtsuka K, Kawaguchi Y, Nishiyama Y (2004) Formation of aggresome-like structures in herpes simplex virus type 2-infected cells and a potential role in virus assembly. Exp Cell Res 299: 486-497.
107. Ng TI, Talarico C, Burnette TC, Biron K, Roizman B (1996) Partial substitution of the functions of the herpes simplex virus 1 U(L)13 gene by the human cytomegalovirus U(L)97 gene. Virology 225: 347-358.
108. Romaker D, Schregel V, Maurer K, Auerochs S, Marzi A, et al. (2006) Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation. J Med Chem 49: 7044-7053.
109. Davison AJ (2007) Comparative Analysis of the Genomes. In: Ann Arvin GC- F, EdwardMocarski, Patrick SMoore, BernardRoizman, RichardWhitley, KoichiYamanishi, eds. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press. pp 10-26.
110. Pellet PE, Roizman B (2007) The Family Herpesviridae: A Brief Introduction. In: David M, Knipe PMH, eds. Fields' Virology. Philadelphia: Lipincott, Williams, and Wilkins. pp 2479-2499.
111. Miller ME, Engel DA, Smith MM (1995) Cyclic AMP signaling is required for function of the N-terminal and CR1 domains of adenovirus E1A in Saccharomyces cerevisiae. Oncogene 11: 1623-1630.
112. Marschall M, Stein-Gerlach M, Freitag M, Kupfer R, van den Bogaard M, et al. (2002) Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy. J Gen Virol 83: 1013-1023.
113. Neipel F, Ellinger K, Fleckenstein B (1991) The unique region of the human herpesvirus 6 genome is essentially collinear with the UL segment of human cytomegalovirus. J Gen Virol 72 (Pt 9): 2293-2297.
114. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
115. Kalejta RF, Bechtel JT, Shenk T (2003) Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23: 1885-1895.
116. Saffert RT, Kalejta RF (2007) Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol 81: 9109-9120.
117. Zhu H, Shen Y, Shenk T (1995) Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69: 7960-7970.
118. Hanks SK, Quinn AM, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52.
119. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325-331.
120. Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395: 237-243.
121. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, et al. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.